Joseph Rajendran

Joseph Rajendran

UNVERIFIED PROFILE

Are you Joseph Rajendran?   Register this Author

Register author
Joseph Rajendran

Joseph Rajendran

Publications by authors named "Joseph Rajendran"

Are you Joseph Rajendran?   Register this Author

52Publications

727Reads

19Profile Views

Venous Thrombosis in Acquired Hemophilia: The Complex Management of Competing Pathologies.

TH Open 2019 Oct 9;3(4):e325-e330. Epub 2019 Oct 9.

Department of Hematology, Tan Tock Seng Hospital, Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1698414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785302PMC
October 2019

Volume dependence in hypoxia-targeted dose escalation.

Med Phys 2018 Nov 1;45(11):5325-5331. Epub 2018 Oct 1.

Department of Radiology, University of Washington, 1959 NE Pacific Street, Seattle, Washington, 98195-6043, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mp.13176DOI Listing
November 2018

Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.

Med Phys 2017 May 28;44(5):1975-1982. Epub 2017 Mar 28.

Department of Radiation Oncology, University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195-6043, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mp.12177DOI Listing
May 2017

F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.

Semin Nucl Med 2015 Mar;45(2):151-62

Department of Radiology, University of Washington, Seattle, WA; Department of Radiation Oncology, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2014.10.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339212PMC
March 2015

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.

Biol Blood Marrow Transplant 2015 Feb 1;21(2):281-7. Epub 2014 Nov 1.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.10.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408880PMC
February 2015

90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution.

Nucl Med Commun 2014 Nov;35(11):1132-42

Departments of aRadiology bMedicine, Division of Medical Oncology, University of Washington Medical Center cClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington dDepartment of Radiology, Harvard Medical School, MGH Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169733PMC
November 2014

Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma.

Biol Blood Marrow Transplant 2014 Jun 12;20(6):770-5. Epub 2014 Feb 12.

Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019701PMC
June 2014

131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testes.

Nucl Med Commun 2012 Dec;33(12):1225-31

aDepartment of Radiology, Division of Nuclear Medicine, University of Washington bFred Hutchinson Cancer Research Center, Seattle cPacific Northwest National Laboratory, Richland, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0b013e328358d34bDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703155PMC
December 2012

Bilateral massive pulmonary thromboembolism in a young patient treated with supportive measures and an inferior vena cava filter with excellent outcome.

Int J Angiol 2010 ;19(3):e116-8

Department of General Medicine, Subspeciality of Vascular Medicine, Tan Tock Seng Hospital, Singapore.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014592PMC
http://dx.doi.org/10.1055/s-0031-1278381DOI Listing
August 2012

Effects of upstaging from PET scan on survival in head and neck squamous cell carcinoma.

Head Neck 2010 Oct;32(10):1283-7

Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.21333DOI Listing
October 2010

Semiquantitative software SPECT analysis in aneurysmal subarachnoid hemorrhage-related vasospasm.

Nucl Med Commun 2010 Jan;31(1):53-8

Department of Radiology, University of Washington School of Medicine, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0b013e328330db10DOI Listing
January 2010

Beyond detection: novel applications for PET imaging to guide cancer therapy.

J Nucl Med 2007 Jun;48(6):855-6

Division of Nuclear Medicine, Department of Radiology, University of Washington, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.107.039768DOI Listing
June 2007

Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.

Clin Cancer Res 2007 Jun;13(12):3460-9

University of Washington and Seattle Cancer Care Alliance, Seattle, Washington , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0074DOI Listing
June 2007

Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes.

Med Phys 2006 Nov;33(11):4280-8

University of Washington, Department of Radiation Oncology, 1959 N. E. Pacific Street, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.2361076DOI Listing
November 2006

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.

Clin Cancer Res 2006 Sep;12(18):5435-41

Department of Radiology, University of Washington, Veterans' Administration Puget Sound Health Care System, Seattle 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-1773DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737549PMC
September 2006

Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy.

Biol Blood Marrow Transplant 2006 Jul;12(7):697-702

Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387910600291
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2006.03.014DOI Listing
July 2006

Expanding role of positron emission tomography in cancer of the uterine cervix.

J Natl Compr Canc Netw 2006 May;4(5):463-9

Division of Nuclear Medicine, Box 356113, University of Washington, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2006.0038DOI Listing
May 2006

[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors.

J Clin Oncol 2005 Dec;23(34):8828-34

Children's Hospital and Regional Medical Center, 4800 Sandpoint Way, Mailstop B-6553, Seattle, WA 98105-0371, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.01.7079DOI Listing
December 2005

FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.

Head Neck 2005 Jun;27(6):478-87

Department of Radiation Oncology, University of Washington, Seattle, Washington, 1660 S. Columbian Way [174], Seattle, WA 98108-1597, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.20177DOI Listing
June 2005

Imaging hypoxia and angiogenesis in tumors.

Radiol Clin North Am 2005 Jan;43(1):169-87

Division of Nuclear Medicine, Department of Radiology, Box 356113, University of Washington, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rcl.2004.08.004DOI Listing
January 2005

FDG-PET prediction of head and neck squamous cell cancer outcomes.

Arch Otolaryngol Head Neck Surg 2004 Dec;130(12):1361-7

Radiation Oncology Service, Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archotol.130.12.1361DOI Listing
December 2004

High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.

J Nucl Med 2004 Jun;45(6):1059-64

Department of Radiology, University of Washington, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
June 2004

Staging of head and neck squamous cell cancer with extended-field FDG-PET.

Arch Otolaryngol Head Neck Surg 2003 Nov;129(11):1173-8

Department of Radiation Oncology, Division of Nuclear Medicine, VA Puget Sound Health Care System and University of Washington, Seattle 98108, USA.

View Article

Download full-text PDF

Source
http://archotol.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archotol.129.11.1173DOI Listing
November 2003

High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation.

J Nucl Med 2002 Oct;43(10):1383-90

Department of Radiology, University of Washington, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
October 2002

Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography.

Cancer 2002 Jun;94(12):3277-84

Department of Pediatrics, Children's Hospital and Regional Medical Center, Seattle, Washington 98105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.10599DOI Listing
June 2002